Caitlin Thornton on Muck Rack

Caitlin Thornton

Los Angeles
As seen in: NerdWallet, Cell Chemical Biology, EBioMedicine, Panama City News Herald, Jacksonville Daily News, News Chief, The Kansan, Butler County Times-Gazette, The Chronicle Express, Redwood Falls Gazette and
writing, branding & content marketing
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Caitlin

Contact Caitlin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Disulfiram metabolite Cu(DDC)2 enhances radionuclide uptake in vivo revealing insights into tumoural ablation resistance

|
By Katie Brookes, Caitlin Thornton, Jessica S. Fear
| EBioMedicine Verified
Keywords Thyroid cancer Breast cancer NIS VCP Proteostasis Transcription Evidence before this study β-emitting radioiodide is a widely used and effective treatment to destroy thyroid cancer cells post-surgery and for targeting metastases. Resistance to radioiodide treatment in aggressive disease reflects the diminished activity of the sodium iodide symporter (NIS), the sole transporter responsible for cellular iodide uptake at the plasma membrane.
Open in Who Shared Issue with article?

Dual agonism of sodium iodide symporter function in vivo

|
By Katie Brookes, Caitlin Thornton, Ling Zha, Jana Kim
| biorxiv.org
Abstract New approaches are urgently needed to enhance the radioiodide (RAI) ablation of aggressive and metastatic thyroid cancer. We recently discovered that valosin-containing protein inhibitors (VCPi) such as clotrimazole and disulfiram transiently block sodium iodide symporter (NIS) proteasomal degradation, hence promoting RAI uptake. However, poor bioavailability diminishes their potential impact in vivo.
Open in Who Shared Issue with article?

Telomerase reactivation induces progression of mouse BrafV600E-driven thyroid cancers without telomere lengthening

|
By Iñigo Landa, Caitlin Thornton, Bin Xu Verified, Jacob Haase
| biorxiv.org
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Open in Who Shared View Duplicates (697) Issue with article?
See all 22 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified